Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. / Jeppesen, P B; Hartmann, B; Thulesen, J; Graff, J; Lohmann, J; Hansen, B S; Tofteng, F; Poulsen, Steen Seier; Madsen, J L; Holst, J J; Mortensen, P B.

In: Gastroenterology, Vol. 120, No. 4, 03.2001, p. 806-815.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jeppesen, PB, Hartmann, B, Thulesen, J, Graff, J, Lohmann, J, Hansen, BS, Tofteng, F, Poulsen, SS, Madsen, JL, Holst, JJ & Mortensen, PB 2001, 'Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon', Gastroenterology, vol. 120, no. 4, pp. 806-815.

APA

Jeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., ... Mortensen, P. B. (2001). Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology, 120(4), 806-815.

Vancouver

Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001 Mar;120(4):806-815.

Author

Jeppesen, P B ; Hartmann, B ; Thulesen, J ; Graff, J ; Lohmann, J ; Hansen, B S ; Tofteng, F ; Poulsen, Steen Seier ; Madsen, J L ; Holst, J J ; Mortensen, P B. / Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. In: Gastroenterology. 2001 ; Vol. 120, No. 4. pp. 806-815.

Bibtex

@article{693ed14074c711dbbee902004c4f4f50,
title = "Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon",
abstract = "Glucagon-like peptide 2 (GLP-2) is intestinotrophic, antisecretory, and transit-modulating in rodents, and it is mainly secreted from the intestinal mucosa of the terminal ileum and colon after food ingestion. We assessed the effect of GLP-2 on the gastrointestinal function in patients without a terminal ileum and colon who have functional short-bowel syndrome with severe malabsorption of wet weight (>1.5 kg/day) and energy (>2.3 MJ/day) and no postprandial secretion of GLP-2.",
keywords = "Adult, Body Composition, Body Weight, Creatinine, Female, Gastrointestinal Hormones, Gastrointestinal Transit, Glucagon-Like Peptide 2, Glucagon-Like Peptides, Hormones, Humans, Injections, Subcutaneous, Intestinal Absorption, Intestines, Male, Middle Aged, Nutritional Status, Patient Compliance, Peptides, Short Bowel Syndrome",
author = "Jeppesen, {P B} and B Hartmann and J Thulesen and J Graff and J Lohmann and Hansen, {B S} and F Tofteng and Poulsen, {Steen Seier} and Madsen, {J L} and Holst, {J J} and Mortensen, {P B}",
year = "2001",
month = "3",
language = "English",
volume = "120",
pages = "806--815",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

AU - Jeppesen, P B

AU - Hartmann, B

AU - Thulesen, J

AU - Graff, J

AU - Lohmann, J

AU - Hansen, B S

AU - Tofteng, F

AU - Poulsen, Steen Seier

AU - Madsen, J L

AU - Holst, J J

AU - Mortensen, P B

PY - 2001/3

Y1 - 2001/3

N2 - Glucagon-like peptide 2 (GLP-2) is intestinotrophic, antisecretory, and transit-modulating in rodents, and it is mainly secreted from the intestinal mucosa of the terminal ileum and colon after food ingestion. We assessed the effect of GLP-2 on the gastrointestinal function in patients without a terminal ileum and colon who have functional short-bowel syndrome with severe malabsorption of wet weight (>1.5 kg/day) and energy (>2.3 MJ/day) and no postprandial secretion of GLP-2.

AB - Glucagon-like peptide 2 (GLP-2) is intestinotrophic, antisecretory, and transit-modulating in rodents, and it is mainly secreted from the intestinal mucosa of the terminal ileum and colon after food ingestion. We assessed the effect of GLP-2 on the gastrointestinal function in patients without a terminal ileum and colon who have functional short-bowel syndrome with severe malabsorption of wet weight (>1.5 kg/day) and energy (>2.3 MJ/day) and no postprandial secretion of GLP-2.

KW - Adult

KW - Body Composition

KW - Body Weight

KW - Creatinine

KW - Female

KW - Gastrointestinal Hormones

KW - Gastrointestinal Transit

KW - Glucagon-Like Peptide 2

KW - Glucagon-Like Peptides

KW - Hormones

KW - Humans

KW - Injections, Subcutaneous

KW - Intestinal Absorption

KW - Intestines

KW - Male

KW - Middle Aged

KW - Nutritional Status

KW - Patient Compliance

KW - Peptides

KW - Short Bowel Syndrome

M3 - Journal article

C2 - 11231933

VL - 120

SP - 806

EP - 815

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -

ID: 168197